Submitted:
13 August 2023
Posted:
14 August 2023
You are already at the latest version
Abstract
Keywords:
Introduction
1. Data and methods
1.1. General data
1.2. Inclusion and exclusion criteria
1.3. Methods
1.4. Observational indicators
1.5. Statistical analysis
2. Results
2.1. Comparison of surgical indicators between the two groups of patients
2.2. Comparison of thyroid function before and after surgery between the two groups
2.3. Comparison of the changes in voice function based on the VHI score between the two groups
3. Discussion
References
- Noda T, Miyauchi A, Ito Y, Kudo T, Sano T, Sasaki T, Ando T, Yamamoto M, Fujishima M, Masuoka H, Higashiyama T, Kihara M, Onoda N, Miya A. Observational management of papillary microcarcinoma appearing in the remnant thyroid after hemithyroidectomy. Endocr J. 2021 Dec 25. Epub ahead of print. PMID: 34955475. [CrossRef]
- Baek HS, Jeong CH, Ha J, Bae JS, Kim JS, Lim DJ, Kim CM. Cost-Effectiveness Analysis of Active Surveillance Compared to Early Surgery in Small Papillary Thyroid Cancer: A Systemic Review. Cancer Manag Res. 2021 Aug 26;13:6721-6730. PMID: 34471385; PMCID: PMC8405161. [CrossRef]
- Zhang L, Ling Y, Zhao Y, Li K, Zhao J, Kang H. A Nomogram Based on Clinicopathological and Ultrasound Imaging Characteristics for Predicting Cervical Lymph Node Metastasis in cN0 Unilateral Papillary Thyroid Microcarcinoma. Front Surg. 2021 Dec 3;8:742328. PMID: 34926565; PMCID: PMC8677692. [CrossRef]
- Cengiz AB, Doruk E. Assessment of Acoustic Voice Parameters After Anterior Cervical Discectomy and Fusion. Cureus. 2021 Dec 22;13(12):e20611. PMID: 35103187; PMCID: PMC8782208. [CrossRef]
- Tseng A M , Peng E T , Bindiganavile S H , et al. Superior oblique myositis following targeted therapy of metastatic papillary carcinoma of the thyroid gland[J]. Canadian Journal of Ophthalmology, 2021, 56(4):688-692. [CrossRef]
- Kim HJ, Cho SJ, Baek JH. Comparison of Thermal Ablation and Surgery for Low-Risk Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-Analysis. Korean J Radiol. 2021 Oct;22(10):1730-1741. PMID: 34585542; PMCID: PMC8484147. [CrossRef]
- Huang C, Cong S, Shang S, Wang M, Zheng H, Wu S, An X, Liang Z, Zhang B. Web-Based Ultrasonic Nomogram Predicts Preoperative Central Lymph Node Metastasis of cN0 Papillary Thyroid Microcarcinoma. Front Endocrinol (Lausanne). 2021 Sep 7;12:734900. PMID: 34557165; PMCID: PMC8453195. [CrossRef]
- Jeon MJ, Kim WG, Kim TY, Shong YK, Kim WB. Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma. Endocrinol Metab (Seoul). 2021 Aug;36(4):717-724. Epub 2021 Aug 11. Erratum in: Endocrinol Metab (Seoul). 2022 Feb;37(1):180. PMID: 34379969; PMCID: PMC8419618. [CrossRef]
- Yu J, Rao S, Lin Z, Pan Z, Zheng X, Wang Z. Correction to: The learning curve of endoscopic thyroid surgery for papillary thyroid microcarcinoma: CUSUM analysis of a single surgeon’s experience. Surg Endosc. 2022 Feb;36(2):1697. Erratum for: Surg Endosc. 2019 Apr;33(4):1284-1289. PMID: 34988745; PMCID: PMC9172745. [CrossRef]
- Orlando G, Scerrino G, Corigliano A, Vitale I, Tutino R, Radellini S, Cupido F, Graceffa G, Cocorullo G, Salamone G, Melfa G. Papillary Thyroid Microcarcinoma: Active Surveillance Against Surgery. Considerations of an Italian Working Group From a Systematic Review. Front Oncol. 2022 Mar 23;12:859461. PMID: 35402255; PMCID: PMC8984605. [CrossRef]
- Shahi S , Bhandari T R , Pantha T , et al. A rare coexistence of papillary carcinoma and anaplastic carcinoma of thyroid in multinodular goitre: Case report and literature review[J]. Annals of Medicine and Surgery, 2020, 56(6):161-164. [CrossRef]
- Peng K, Zhou P, Liu W. Long-Term Efficacy of Ultrasound-Guided Percutaneous Laser Ablation for Low-Risk Papillary Thyroid Microcarcinoma: A 5-Year Follow-Up Study. Biomed Res Int. 2021 Jul 23;2021:6616826. PMID: 34337037; PMCID: PMC8324339. [CrossRef]
- Malik AA, Aziz F, Beshyah SA, Aldahmani KM. Characteristics and Management of Papillary Thyroid Microcarcinoma in the United Arab Emirates: Experience from a Large Tertiary Hospital. Saudi J Med Med Sci. 2022 Jan-Apr;10(1):42-48. Epub 2022 Jan 17. PMID: 35283703; PMCID: PMC8869268. [CrossRef]
- Du J, Han R, Chen C, Ma X, Shen Y, Chen J, Li F. Diagnostic Efficacy of Ultrasound, Cytology, and BRAFV600E Mutation Analysis and Their Combined Use in Thyroid Nodule Screening for Papillary Thyroid Microcarcinoma. Front Oncol. 2022 Jan 3;11:746776. PMID: 35047385; PMCID: PMC8761628. [CrossRef]
| Groups | Incision length (cm) | Intraoperative blood loss(ml) | Operation time (min) | Drainage volume(ml) | Hospital stay(d) |
|---|---|---|---|---|---|
| Control group(n=34) | 8.95±0.12 | 73.25±2.25 | 119.25±10.25 | 78.12±2.02 | 6.08±0.25 |
| Observation group (n=34) | 6.01±0.21 | 50.21±1.25 | 73.25±6.32 | 47.25±1.25 | 4.12±0.12 |
| t | 12.325 | 13.325 | 14.254 | 15.235 | 16.231 |
| P | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
| Groups | Time | FT4(pmol/L) | FT3(pmol/L) | TSH(mIU/L) |
|---|---|---|---|---|
| Control group(n=34) | Day of admission | 13.25±1.72 | 4.12±0.12 | 2.40±0.21 |
| 1 month after surgery | 11.02±0.92 | 3.61±0.09 | 10.29±1.22 | |
| t | - | 15.254 | 14.251 | 13.324 |
| P | - | <0.001 | <0.001 | <0.001 |
| Observation group(n=34) | Day of admission | 13.28±1.71 | 4.13±0.13 | 2.38±0.15 |
| 1 month after surgery | 13.92±0.12 | 4.71±0.07 | 1.54±0.19 | |
| t | - | 14.235 | 13.254 | 12.952 |
| P | - | <0.001 | <0.001 | <0.001 |
| Groups | Time | Emotions | Functions | Physiology |
|---|---|---|---|---|
| Control group (n=34) | One week after surgery | 23.32±5.21 | 31.25±5.65 | 32.18±5.74 |
| One month after surgery | 20.12±4.25 | 25.32±4.12 | 26.32±4.02 | |
| t | - | 12.254 | 13.254 | 14.254 |
| P | - | <0.001 | <0.001 | <0.001 |
| Observation group(n=34) | One week after surgery | 23.15±5.32 | 31.12±5.61 | 32.18±5.14 |
| One month after surgery | 16.32±3.24 | 20.12±3.92 | 21.23±3.25 | |
| t | - | 13.254 | 14.254 | 14.245 |
| P | - | <0.001 | <0.001 | <0.001 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).